vs
Side-by-side financial comparison of AerSale Corp (ASLE) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $85.1M, roughly 1.1× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 5.9%, a 16.9% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -4.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $9.8M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
ASLE vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $85.1M |
| Net Profit | $5.4M | $19.4M |
| Gross Margin | 34.1% | — |
| Operating Margin | 7.8% | 17.3% |
| Net Margin | 5.9% | 22.8% |
| Revenue YoY | -4.0% | 8508900.0% |
| Net Profit YoY | 99.7% | 139.1% |
| EPS (diluted) | $0.10 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $85.1M | ||
| Q3 25 | $71.2M | $90.0K | ||
| Q2 25 | $107.4M | $15.0K | ||
| Q1 25 | $65.8M | $14.0K | ||
| Q4 24 | $94.7M | $1.0K | ||
| Q3 24 | $82.7M | $3.0K | ||
| Q2 24 | $77.1M | $5.0K | ||
| Q1 24 | $90.5M | $28.0K |
| Q4 25 | $5.4M | $19.4M | ||
| Q3 25 | $-120.0K | $-56.9M | ||
| Q2 25 | $8.6M | $-54.7M | ||
| Q1 25 | $-5.3M | $-48.0M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $509.0K | $-43.8M | ||
| Q2 24 | $-3.6M | $-35.0M | ||
| Q1 24 | $6.3M | $-32.4M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 30.2% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 7.8% | 17.3% | ||
| Q3 25 | 4.0% | -67983.3% | ||
| Q2 25 | 11.7% | -396373.3% | ||
| Q1 25 | -10.1% | -383007.1% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 2.4% | -1704400.0% | ||
| Q2 24 | -2.4% | -849120.0% | ||
| Q1 24 | 5.2% | -136200.0% |
| Q4 25 | 5.9% | 22.8% | ||
| Q3 25 | -0.2% | -63195.6% | ||
| Q2 25 | 8.0% | -364386.7% | ||
| Q1 25 | -8.0% | -342657.1% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.6% | -1461433.3% | ||
| Q2 24 | -4.7% | -699060.0% | ||
| Q1 24 | 6.9% | -115717.9% |
| Q4 25 | $0.10 | $0.43 | ||
| Q3 25 | $0.00 | $-1.01 | ||
| Q2 25 | $0.18 | $-0.98 | ||
| Q1 25 | $-0.10 | $-0.86 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | $-0.79 | ||
| Q2 24 | $-0.07 | $-0.63 | ||
| Q1 24 | $0.12 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $402.7M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $505.7M |
| Total Assets | $640.5M | $566.7M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $402.7M | ||
| Q3 25 | $5.3M | $305.1M | ||
| Q2 25 | $5.7M | $293.2M | ||
| Q1 25 | $4.7M | $321.4M | ||
| Q4 24 | $4.7M | $424.9M | ||
| Q3 24 | $9.8M | $501.9M | ||
| Q2 24 | $4.3M | $541.9M | ||
| Q1 24 | $2.6M | $525.9M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $505.7M | ||
| Q3 25 | $417.1M | $369.0M | ||
| Q2 25 | $415.9M | $420.9M | ||
| Q1 25 | $406.5M | $469.7M | ||
| Q4 24 | $455.6M | $510.6M | ||
| Q3 24 | $451.5M | $552.9M | ||
| Q2 24 | $449.8M | $588.3M | ||
| Q1 24 | $452.0M | $600.6M |
| Q4 25 | $640.5M | $566.7M | ||
| Q3 25 | $646.3M | $424.0M | ||
| Q2 25 | $646.7M | $473.6M | ||
| Q1 25 | $646.1M | $515.7M | ||
| Q4 24 | $604.7M | $560.4M | ||
| Q3 24 | $601.5M | $604.0M | ||
| Q2 24 | $598.7M | $620.1M | ||
| Q1 24 | $571.7M | $629.9M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $28.6M |
| Free Cash FlowOCF − Capex | $9.8M | $28.5M |
| FCF MarginFCF / Revenue | 10.8% | 33.5% |
| Capex IntensityCapex / Revenue | 1.7% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.11× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $28.6M | ||
| Q3 25 | $-8.9M | $-46.5M | ||
| Q2 25 | $19.8M | $-43.4M | ||
| Q1 25 | $-45.2M | $-47.8M | ||
| Q4 24 | $37.5M | $-134.6M | ||
| Q3 24 | $10.4M | $-29.4M | ||
| Q2 24 | $-15.3M | $-30.2M | ||
| Q1 24 | $-21.5M | $-29.1M |
| Q4 25 | $9.8M | $28.5M | ||
| Q3 25 | $-9.8M | $-46.6M | ||
| Q2 25 | $18.6M | $-43.4M | ||
| Q1 25 | $-47.6M | $-48.4M | ||
| Q4 24 | $32.3M | $-138.4M | ||
| Q3 24 | $8.9M | $-31.2M | ||
| Q2 24 | $-18.9M | $-30.6M | ||
| Q1 24 | $-25.0M | $-29.8M |
| Q4 25 | 10.8% | 33.5% | ||
| Q3 25 | -13.8% | -51765.6% | ||
| Q2 25 | 17.3% | -289620.0% | ||
| Q1 25 | -72.4% | -345635.7% | ||
| Q4 24 | 34.0% | -13837100.0% | ||
| Q3 24 | 10.7% | -1038966.7% | ||
| Q2 24 | -24.6% | -611840.0% | ||
| Q1 24 | -27.7% | -106421.4% |
| Q4 25 | 1.7% | 0.1% | ||
| Q3 25 | 1.3% | 101.1% | ||
| Q2 25 | 1.1% | 440.0% | ||
| Q1 25 | 3.7% | 4507.1% | ||
| Q4 24 | 5.6% | 378600.0% | ||
| Q3 24 | 1.9% | 59266.7% | ||
| Q2 24 | 4.7% | 6980.0% | ||
| Q1 24 | 3.9% | 2535.7% |
| Q4 25 | 2.11× | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
FDMT
Segment breakdown not available.
